These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 28874142)

  • 1. Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients.
    da Silva TP; Giacoia-Gripp CBW; Schmaltz CA; Sant'Anna FM; Saad MH; Matos JA; de Lima E Silva JCA; Rolla VC; Morgado MG
    BMC Infect Dis; 2017 Sep; 17(1):606. PubMed ID: 28874142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens.
    Vignesh R; Kumarasamy N; Lim A; Solomon S; Murugavel KG; Balakrishnan P; Solomon SS; Mayer KH; Swathirajan CR; Chandrasekaran E; Pradeep A; Poongulali S; Benson CA; French MA
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):241-8. PubMed ID: 23774879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Ravimohan S; Tamuhla N; Nfanyana K; Steenhoff AP; Letlhogile R; Frank I; MacGregor RR; Gross R; Weissman D; Bisson GP
    Clin Infect Dis; 2016 Mar; 62(6):795-803. PubMed ID: 26611774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.
    Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA
    J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
    Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
    BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.
    Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA
    J Infect; 2014 Apr; 68(4):344-54. PubMed ID: 24325926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.
    Meintjes G; Wilkinson KA; Rangaka MX; Skolimowska K; van Veen K; Abrahams M; Seldon R; Pepper DJ; Rebe K; Mouton P; van Cutsem G; Nicol MP; Maartens G; Wilkinson RJ
    Am J Respir Crit Care Med; 2008 Nov; 178(10):1083-9. PubMed ID: 18755923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
    Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
    AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS.
    Goovaerts O; Jennes W; Massinga-Loembé M; Ceulemans A; Worodria W; Mayanja-Kizza H; Colebunders R; Kestens L;
    PLoS One; 2014; 9(11):e113101. PubMed ID: 25415590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome.
    Chakrabarti LA; Boucherie C; Bugault F; Cumont MC; Roussillon C; Breton G; Patey O; Chêne G; Richert L; Lortholary O;
    AIDS; 2014 Jul; 28(11):1593-602. PubMed ID: 24865974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children.
    Connell TG; Davies MA; Johannisen C; Wood K; Pienaar S; Wilkinson KA; Wilkinson RJ; Zar HJ; Beatty D; Nicol MP; Curtis N; Eley B
    BMC Infect Dis; 2010 May; 10():138. PubMed ID: 20507549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
    Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
    Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome.
    Tran HT; Van den Bergh R; Vu TN; Laukens K; Worodria W; Loembé MM; Colebunders R; Kestens L; De Baetselier P; Raes G;
    Immunobiology; 2014 Jan; 219(1):37-44. PubMed ID: 23958034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skewing of the CD4(+) T-cell pool toward monofunctional antigen-specific responses in patients with immune reconstitution inflammatory syndrome in The Gambia.
    Wilson H; de Jong BC; Peterson K; Jaye A; Kampmann B; Ota MO; Sutherland JS
    Clin Infect Dis; 2013 Aug; 57(4):594-603. PubMed ID: 23645847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
    Oliver BG; Elliott JH; Price P; Phillips M; Cooper DA; French MA
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):287-92. PubMed ID: 22732467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
    Dirix V; Schepers K; Massinga-Loembe M; Worodria W; Colebunders R; Singh M; Locht C; Kestens L; Mascart F;
    J Acquir Immune Defic Syndr; 2016 Jul; 72(3):344-52. PubMed ID: 27306506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation.
    Hsieh SM; Hung CC; Pan SC; Wang JT; Tsai HC; Chen MY; Chang SC
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):212-20. PubMed ID: 11115951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients.
    Valin N; Pacanowski J; Denoeud L; Lacombe K; Lalande V; Fonquernie L; Girard PM; Meynard JL
    AIDS; 2010 Jun; 24(10):1519-25. PubMed ID: 20549841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection.
    Silveira H; Ordway D; Dockrell H; Jackson M; Ventura F
    Clin Exp Immunol; 1997 Oct; 110(1):26-34. PubMed ID: 9353145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.